Skip to main content
Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
1.230
-0.050 (-3.91%)
At close: Apr 28, 2026, 4:00 PM EDT
1.250
+0.020 (1.63%)
After-hours: Apr 28, 2026, 7:35 PM EDT

Pulmonx Revenue

In the year 2025, Pulmonx had annual revenue of $90.50M with 8.01% growth. Pulmonx had revenue of $22.60M in the quarter ending December 31, 2025, a decrease of -4.91%.

Revenue (ttm)
$90.50M
Revenue Growth
+8.01%
P/S Ratio
0.57
Revenue / Employee
$305,733
Employees
296
Market Cap
51.95M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202590.50M6.71M8.01%
Dec 31, 202483.79M15.11M22.01%
Dec 31, 202368.68M15.01M27.98%
Dec 31, 202253.66M5.25M10.84%
Dec 31, 202148.42M15.68M47.91%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Accuray 436.97M
LENSAR 58.44M
electroCore 32.03M
Sensus Healthcare 27.48M
Baird Medical Investment Holdings 22.54M
Spectral AI 19.65M
InspireMD 8.98M
Picard Medical 4.94M
Revenue Rankings

LUNG News

More News